DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...

Sciences announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the ...

This was the stock's third consecutive day of gains.

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

We recently published a list of 10 Stocks That Analysts Think Will Go Up. In this article, we are going to take a look at ...

Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives ...

Assembly Biosciences (ASMB) announced promising interim results from its ongoing Phase 1a/b study of ABI-1179, an ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Gilead Sciences (GILD) been one of those stocks this year? Let's take a closer ...

Over the last 7 days, the United States market has risen by 1.2%, contributing to a substantial climb of 24% over the past year, with earnings anticipated to grow by 15% annually. In such a robust ...

Gilead Sciences's GILD short percent of float has fallen 8.91% since its last report. The company recently reported that it ...

Gilead (GILD) announced that the FDA has accepted its new drug application submissions for lenacapavir, the company’s twice-yearly injectable ...